Celltrion gets approval to trial antibody-based Covid-19 treatment
Celltrion Group has received approval from the Korean Ministry of Food and Drug Safety (MFDS)...
Celltrion starts Phase I Covid-19 trial of antibody candidate
Celltrion Group has initiated a Phase I clinical trial of its investigational antiviral antibody candidate...
IVI and SNU partner to trial Inovio’s Covid-19 vaccine in Korea
The International Vaccine Institute (IVI) and Seoul National University (SNU) Hospital have partnered to conduct...
Neo and FLETA collaborate on trial data registry platform launch
Korean-based project FLETA has formed a strategic collaboration with Chinese blockchain giant Neo on the...
Inovio gets grant to partner with IVI and KNIH for Covid-19 vaccine
Inovio Pharmaceuticals has received $6.9m in funding from the Coalition for Epidemic Preparedness Innovations (CEPI)...
COVID-19 coronavirus: Top ten most-affected countries
One Asian country and seven European countries are among the ten most affected list of...
Coronavirus in South Korea: COVID-19 outbreak, measures and impact
Neighbouring two coronavirus-affected countries China and Japan, South Korea is among the top ten countries...
I-Mab seeks approval for Covid-19 trial in South Korea
I-Mab Biopharma has filed an investigational new drug (IND) application with South Korea’s Ministry of...
Clinerion and PPC join forces on clinical trials acceleration
Clinical research services provider Clinerion has partnered with PPC to offer Patient Network Explorer services...
ESMO 2019: BeiGene presents data on tislelizumab and pamiparib
Biopharmaceutical company BeiGene has presented data on its two investigational drug candidates, anti-PD-1 antibody tislelizumab...